Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Schedule of Segment Information (Details)

v3.20.1
Segment Reporting - Schedule of Segment Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Net revenues - External $ 15,986,924 $ 14,548,690
Loss from operations (47,256,310) (12,821,442)
Depreciation and amortization 795,201 1,263,844
Capital expenditures 127 213,105
Total assets 14,707,659 14,199,300
Hospital Operations [Member]    
Net revenues - External 15,927,983 14,417,676
Loss from operations (11,060,401) (6,434,538)
Depreciation and amortization 715,286 498,352
Capital expenditures 127 213,105
Total assets 14,275,256 13,568,933
Clinical Laboratory Operations [Member]    
Net revenues - External 58,941 131,014
Loss from operations (1,061,145) (2,247,499)
Depreciation and amortization 79,232 764,445
Capital expenditures
Total assets 330,381 271,426
Corporate [Member]    
Loss from operations (4,209,378) (4,542,583)
Depreciation and amortization 683 1,047
Total assets 2,305,380 2,707,416
Assets of AMSG and HTS Classified as Held for Sale [Member]    
Total assets 514,772 152,171
Eliminations [Member]    
Total assets $ (2,718,130) $ (2,500,646)